Perrigo (PRGO) Change in Cash (2013 - 2026)
Perrigo's (PRGO) quarterly Change in Cash came in at -$174.4 million in Q1 2026, down 23.08% year-on-year from -$226.7 million in Q1 2025, and down 275.28% on a QoQ basis from $99.5 million in Q4 2025.
Perrigo (PRGO) Change in Cash (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Change in Cash data on file, last reported at -$174.4 million in Q1 2026.
- On a quarterly basis, Change in Cash fell 23.08% year-over-year to -$174.4 million in Q1 2026; TTM through Mar 2026 was -$57.6 million, a 76.14% increase from a year earlier, with the FY2025 full-year figure at -$24.9 million, up 87.06% from the prior year.
- Change in Cash for Q1 2026 stood at -$174.4 million, down from $99.5 million in the prior quarter.
- Over the last five years, Change in Cash for PRGO reached as high as $920.7 million in Q3 2024 and fell as low as -$1.5 billion in Q3 2022.
- Historically, Change in Cash has averaged -$89.4 million across 5 years, with a median of -$16.6 million in 2022.
- On a YoY basis, Change in Cash climbed as much as 2036.19% in 2024 and fell as far as 5359.09% in 2024.
- Year by year, Change in Cash stood at $132.0 million in 2022, then rose by 15.91% to $153.0 million in 2023, then sank by 691.31% to -$904.7 million in 2024, then jumped by 111.0% to $99.5 million in 2025, then sank by 275.28% to -$174.4 million in 2026.
- Per Business Quant data, the three most recent Change in Cash figures were -$174.4 million in Q1 2026, $99.5 million in Q4 2025, and -$19.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | -174.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -174.40 Mn |
| Dec 31, 2025 | 99.50 Mn |
| Sep 27, 2025 | -19.80 Mn |
| Jun 28, 2025 | 37.10 Mn |
| Mar 29, 2025 | -141.70 Mn |
| Dec 31, 2024 | -904.70 Mn |
| Sep 28, 2024 | 920.70 Mn |
| Jun 29, 2024 | -115.70 Mn |
| Mar 30, 2024 | -92.80 Mn |
| Dec 31, 2023 | 153.00 Mn |
| Sep 30, 2023 | 43.10 Mn |
| Jul 1, 2023 | 2.20 Mn |
| Apr 1, 2023 | -47.70 Mn |
| Dec 31, 2022 | 132.00 Mn |
| Oct 1, 2022 | -16.60 Mn |
| Jul 2, 2022 | -1.48 Bn |
| Apr 2, 2022 | 86.20 Mn |
| Dec 31, 2021 | -208.90 Mn |
| Oct 2, 2021 | 1.75 Bn |
| Jul 3, 2021 | -144.50 Mn |